Adrian Bekier
Lodz, LD 92213, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Effects of Budesonide on Coronavirus-Associated Receptor and Immune-Mediator Expression in Human Lung Microvascular Endothelial Cells.
Journal: Medicina (Kaunas, Lithuania)
Published: June 12, 2026
Fungemia caused by Cyberlindnera fabianii: Clinical and microbiological insights from two fatal cases.
Journal: Medical mycology case reports
Published: June 08, 2026
Identification of Quinoline Tethered Thiadiazole/Thiazole Derivatives as Potent Tyrosinase Inhibitors With Promising Anti-Toxoplasma gondii Agents: Design, Synthesis, and Computational Analysis.
Journal: Drug development research
Published: April 11, 2026
Changes in Susceptibility Profiles of Acinetobacter baumannii Clinical Isolates in a Multi-Profile Hospital in Years 2020-2024 in Lodz, Poland.
Journal: Journal of clinical medicine
Published: March 09, 2026
Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosis.
Journal: Frontiers in immunology
Published: December 16, 2025
Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect.
Journal: International journal of molecular sciences
Published: September 06, 2025
Rhinoviral Infection of the Human Lung Vascular Endothelium May Protect From the Secondary Infection With Rhinovirus RV-16.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: September 18, 2024
Analysis of miRNA Expression in Patients With NSAID-Exacerbated Respiratory Disease.
Journal: Allergy, asthma & immunology research
Published: July 26, 2024
Development of a prototypic, field-usable diagnostic tool for the detection of gram-positive cocci-induced mastitis in cattle.
Journal: BMC veterinary research
Published: November 24, 2023
TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents.
Journal: International journal of molecular sciences
Published: December 05, 2022
Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: September 27, 2022
Last Updated: 09/26/2026